IP Library Granted Patent US 10,087,445
Granted Patent B2
US 10,087,445 · App. 15/360,382 · Granted Oct 2, 2018

Modifications for antisense compounds

Inventors: Mark Aaron Behlke (Coralville, IA); Richard Owczarzy (Coralville, IA); Yong You (Iowa City, IA); Joseph Alan Walder (Chicago, IL); Kim Lennox (North Liberty, IA)
Assignee: Integrated DNA Technologies, Inc.
C12N15/113C12N15/111C12Q1/6876C12N2310/11C12N2310/141C12N2310/315C12N2310/321C12N2310/344C12N2310/352C12N2310/3529C12N2320/51
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,087,445
App. No.
15/360,382
Granted
Oct 2, 2018
Kind
B2
Abstract

The invention pertains to modifications for antisense oligonucleotides, wherein the modifications are used to improve stability and provide protection from nuclease degradation. The modifications could also be incorporated into double-stranded nucleic acids, such as synthetic siRNAs and miRNAs.

Claims (16)

1. A method of detecting a target oligonucleotide in a sample, the method comprising:

(a) contacting the sample with a composition comprising a probe oligonucleotide capable of hybridizing with the target oligonucleotide, the probe oligonucleotide having the structure 5′-Y 1 —X—Y 2 -3′, wherein

Y 1 comprises a fluorophore at or near the 5′-terminus of the probe oligonucleotide and a sequence of 8-12 DNA or RNA nucleotides comprising a nucleotide N 1 having a 3′ phosphate covalently linked to X;

Y 2 comprises a quencher located at or near the 3′-terminus of the probe oligonucleotide and a sequence of DNA or RNA nucleotides comprising a nucleotide N 2 having a 5′ phosphate covalently linked to X; and

X comprises an internal quencher;

wherein fluorescence of the fluorophore is reduced when the probe oligonucleotide is not hybridized to the target oligonucleotide; and

(b) detecting the presence of the target oligonucleotide in the sample when an increase in fluorescence of the composition is detected as compared to the fluorescence of the composition in a control sample devoid of the target oligonucleotide.

2. The method of claim 1 , wherein the quencher located at or near the 3′-terminus of the probe oligonucleotide is dabcyl, Eclipse® quencher, Black Hole quencher BHQ1, Black Hole quencher BHQ2, Black Hole quencher BHQ3, Iowa Black® FQ, Iowa Black® RQ-n1, or Iowa Black® RQ-n2.

3. The method of claim 1 , wherein the internal quencher is dabcyl, Eclipse® quencher, Black Hole quencher BHQ1, Black Hole quencher BHQ2, Black Hole quencher BHQ3, Iowa Black® FQ, Iowa Black® RQ-n1, or Iowa Black® RQ-n2.

4. The method of claim 1 , wherein fluorescence of the fluorophore is reduced by fluorescence resonance energy transfer, ground state quenching, or a combination thereof when the probe oligonucleotide is not hybridized to the target oligonucleotide.

5. The method of claim 1 , wherein the increase in fluorescence arises from cleavage of the probe oligonucleotide.

6. The method of claim 1 , wherein the probe oligonucleotide forms a random-coil conformation when the probe oligonucleotide is unhybridized, such that the fluorescence of the fluorophore is reduced.

7. The method of claim 1 , wherein the probe oligonucleotide comprises a self-complementary sequence and wherein the quencher and the fluorophore are attached to the probe oligonucleotide such that the fluorescence of the fluorophore is quenched when the probe oligonucleotide undergoes intramolecular base pairing.

8. The method of claim 1 , wherein the method is used in a polymerase chain reaction (PCR), wherein synthesis of PCR product results in an increase in fluorescence.

9. The method of claim 1 wherein the stability of an oligonucleotide duplex comprising the probe oligonucleotide is greater than the stability of an oligonucleotide duplex comprising a comparator probe oligonucleotide lacking an internal quencher.

10. The method of claim 1 , wherein Y 1 comprises a fluorophore at the 5′-terminus of the probe oligonucleotide and a sequence of 9 DNA or RNA nucleotides comprising a nucleotide N 1 having a 3′ phosphate covalently linked to X.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2018
From: BEHLKE, MARK AARON; OWCZARZY, RICHARD; YOU, YONG; WALDER, JOSEPH ALAN; LENNOX, KIM
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 045791/0094 →
Continuity (6)
Continuation 14281646 · May 19, 2014
Continuation 13227286 · Sep 7, 2011
Continuation In Part 13073866 · Mar 28, 2011
Provisional Application 61380586 · Sep 7, 2010
Provisional Application 61318043 · Mar 26, 2010
Related Publication 20170204412A1 · Jul 20, 2017